USA — Merck & Co. has exercised a US$250-million option with Moderna to jointly develop and commercialize personalized mRNA cancer vaccine candidates. Merck & Co. will pay Moderna US$250 million…
Read MoreTag: Merck
Larger-scale acquisitions in Merck’s purview moving into the new year
GERMANY – Merck KGaA has announced that it will reconsider potential larger-scale acquisitions next year, in addition to in-licensing and bolt-on purchases, to support its growth, FirstWord Pharma reports. Merck…
Read MoreMilliporeSigma opens a commercial facility for CTDMO services in France
FRANCE – MilliporeSigma’s life science business sector has opened a commercial facility in Martillac, France, for its new contract testing development and manufacturing organization (CTDMO) services offering. MilliporeSigma, the life…
Read MoreKenya hosts Merck Foundation annual summit on patient care transformation
KENYA – Merck Foundation has conducted their Annual Kenya Alumni Summit in Nairobi to discuss their programs with their partners and beneficiaries to transform patient care landscape in Kenya through…
Read MoreNovartis hires MSD executive Fiona Marshall as head of research
SWITZERLAND- Fiona Marshall, a Merck executive, has been named president of the Novartis Institutes for Biomedical Research (NIBR)to succeed Jay Bradner. James (Jay) E. Bradner, M.D., will step down from…
Read MoreMerck India launches Healthcare R&D Excellence Centre facility
INDIA- Merck has established a Healthcare R&D Excellence Center facility that will help develop future medical treatments for individuals with unmet medical requirements all around the world. The R&D Excellence…
Read MorePharma Merck announces significant developments in ESG target areas
USA- Merck has released its 2021/2022 Environmental, Social, and Governance (ESG) Growth Report, which highlights the company’s performance and progress in four ESG emphasis areas The ESG areas include; Access…
Read MoreStartupbootcamp AfriTech initites US$7m program to scale up digital health solutions
SOUTH AFRICA – South African Startupbootcamp AfriTech (SBC) has partnered with Moroccan consulting firm Southbridge A&I and its Canadian partner Salient Advisory to launch a US$7 million innovator support program…
Read MoreMerck reportedly mulling Seagen acquisition
USA – A report in The Wall Street Journal has said Merck & Co. is considering a buyout of Seagen, a pioneer in the use of antibody-drug conjugates (ADCs) to…
Read MoreMerck unveils plans to launch cancer care and thyroid awareness programs in Africa
AFRICA – Leading science and technology company Merck has announced the upcoming launch of the Africa Cancer Care program to enhance colorectal cancer diagnosis across Africa and new thyroid awareness…
Read More